AU2003264386A1 - 4-(substituted aryl)-5-hydroxyisoquinolinone derivative - Google Patents
4-(substituted aryl)-5-hydroxyisoquinolinone derivativeInfo
- Publication number
- AU2003264386A1 AU2003264386A1 AU2003264386A AU2003264386A AU2003264386A1 AU 2003264386 A1 AU2003264386 A1 AU 2003264386A1 AU 2003264386 A AU2003264386 A AU 2003264386A AU 2003264386 A AU2003264386 A AU 2003264386A AU 2003264386 A1 AU2003264386 A1 AU 2003264386A1
- Authority
- AU
- Australia
- Prior art keywords
- substituted aryl
- hydroxyisoquinolinone
- derivative
- hydroxyisoquinolinone derivative
- aryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002-263918 | 2002-09-10 | ||
JP2002263918 | 2002-09-10 | ||
PCT/JP2003/011346 WO2004024694A1 (en) | 2002-09-10 | 2003-09-05 | 4-(substituted aryl)-5-hydroxyisoquinolinone derivative |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003264386A1 true AU2003264386A1 (en) | 2004-04-30 |
Family
ID=31986476
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003264386A Abandoned AU2003264386A1 (en) | 2002-09-10 | 2003-09-05 | 4-(substituted aryl)-5-hydroxyisoquinolinone derivative |
Country Status (3)
Country | Link |
---|---|
JP (1) | JPWO2004024694A1 (en) |
AU (1) | AU2003264386A1 (en) |
WO (1) | WO2004024694A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9078888B2 (en) | 2007-01-22 | 2015-07-14 | Gtx, Inc. | Nuclear receptor binding agents |
US9604931B2 (en) | 2007-01-22 | 2017-03-28 | Gtx, Inc. | Nuclear receptor binding agents |
US9623021B2 (en) | 2007-01-22 | 2017-04-18 | Gtx, Inc. | Nuclear receptor binding agents |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007008816A (en) * | 2003-10-15 | 2007-01-18 | Ube Ind Ltd | New isoquinoline derivative |
DE102004028973A1 (en) * | 2004-06-16 | 2006-01-05 | Sanofi-Aventis Deutschland Gmbh | Substituted tetrahydro-2H-isoquinolin-1-one derivatives, process for their preparation and their use as medicaments |
CA2637530A1 (en) * | 2006-01-18 | 2007-09-07 | Siena Biotech S.P.A. | Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof |
WO2011010131A1 (en) * | 2009-07-21 | 2011-01-27 | Astrazeneca Ab | Compositions comprising an oxoisoquinoline methylbenzamide and a polymer |
WO2011058367A2 (en) | 2009-11-13 | 2011-05-19 | Astrazeneca Ab | Diagnostic test for predicting responsiveness to treatment with poly(adp-ribose) polymerase (parp) inhibitor |
US9173395B2 (en) | 2011-07-04 | 2015-11-03 | Bayer Intellectual Property Gmbh | Use of substituted isoquinolinones, isoquinolindiones, isoquinolintriones and dihydroisoquinolinones or in each case salts thereof as active agents against abiotic stress in plants |
WO2013176970A1 (en) * | 2012-05-22 | 2013-11-28 | Merck Sharp & Dohme Corp. | TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF |
AR092742A1 (en) | 2012-10-02 | 2015-04-29 | Intermune Inc | ANTIFIBROTIC PYRIDINONES |
EP3252049A1 (en) | 2013-01-18 | 2017-12-06 | Bristol-Myers Squibb Company | Phthalazinones and isoquinolinones as rock inhibitors |
US9902702B2 (en) | 2014-07-15 | 2018-02-27 | Bristol-Myers Squibb Company | Spirocycloheptanes as inhibitors of rock |
DK3191450T3 (en) | 2014-09-10 | 2019-05-20 | Glaxosmithkline Ip Dev Ltd | PYRIDOND DERIVATIVES AS KINASE ACCESSORIES UNDER TRANSFECTION (RET) |
PE20170677A1 (en) | 2014-09-10 | 2017-05-13 | Glaxosmithkline Ip Dev Ltd | NEW COMPOUNDS AS REORGANIZED INHIBITORS DURING TRANSFECTION (RET) |
EP3615026B1 (en) | 2017-04-28 | 2021-03-03 | Akribes Biomedical GmbH | A parp inhibitor in combination with a glucocorticoid and/or ascorbic acid and/or a protein growth factor for the treatment of impaired wound healing |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4897391A (en) * | 1988-06-17 | 1990-01-30 | Schering Corporation | Tricyclic anti-allergy, antiinflammatory and anti-hyperproliferative compounds |
WO2002044157A2 (en) * | 2000-12-01 | 2002-06-06 | Iconix Pharmaceuticals, Inc. | Parb inhibitors |
JPWO2002094790A1 (en) * | 2001-05-23 | 2004-09-09 | 三菱ウェルファーマ株式会社 | Fused heterocyclic compounds and their pharmaceutical uses |
-
2003
- 2003-09-05 WO PCT/JP2003/011346 patent/WO2004024694A1/en active Application Filing
- 2003-09-05 JP JP2004535899A patent/JPWO2004024694A1/en active Pending
- 2003-09-05 AU AU2003264386A patent/AU2003264386A1/en not_active Abandoned
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9078888B2 (en) | 2007-01-22 | 2015-07-14 | Gtx, Inc. | Nuclear receptor binding agents |
US9604931B2 (en) | 2007-01-22 | 2017-03-28 | Gtx, Inc. | Nuclear receptor binding agents |
US9623021B2 (en) | 2007-01-22 | 2017-04-18 | Gtx, Inc. | Nuclear receptor binding agents |
Also Published As
Publication number | Publication date |
---|---|
JPWO2004024694A1 (en) | 2006-01-05 |
WO2004024694A1 (en) | 2004-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003211362A1 (en) | N-hydroxycarboxamide derivative | |
AU2003255492A1 (en) | Heterocyclic derivatives | |
AU2003224111A1 (en) | Substituted pyrazolo-pyrimidine-4-ones | |
EP1682493B8 (en) | Amidoacetonitrile derivatives | |
AU2003248259A1 (en) | Novel azetidine derivative or salt thereof | |
AU2003279366A1 (en) | Novel compounds | |
WO2003072535A8 (en) | Substituted hydroxyethylamines | |
EP1606277B8 (en) | Imidazol-4-yl-ethynyl-pyridine derivatives | |
AU2003238043A1 (en) | Substituted imidazotriazines | |
AU2003245984A1 (en) | Hetero-cyclicaly substituted imidazotriazines | |
AU2003273064A1 (en) | Quinoline-3-carboxamide compound | |
AU2003264386A1 (en) | 4-(substituted aryl)-5-hydroxyisoquinolinone derivative | |
AU2003301968A1 (en) | 4-aminomethyl-1-aryl-cyclohexylamine derivatives | |
AU2003231388A1 (en) | Novel piperidine derivative | |
AU2003264753A1 (en) | 1-sulphonyl piperidine derivatives | |
AU2003294900A1 (en) | Substituted 5-aminomethyl-1h-pyrrole-2-carboxamides | |
AU2003303648A1 (en) | Novel 5-hydroxyindole-3-carboxylate derivatives | |
EP1706373B8 (en) | Amidoacetonitrile derivatives | |
AU2003278369A1 (en) | 3-cyano-quinoline derivatives | |
AU2003296564A1 (en) | 4-hydroxymethyl-1-aryl-cyclohexylamine derivatives | |
AU2003222659A1 (en) | 23-o-substituted 5-o-mycaminosyltylonide derivatives | |
AU2003234131A1 (en) | 5-o-mycaminosyltylonide derivatives | |
AU2003212366A1 (en) | Substituted 4-aminocyclohexanols | |
AU2003274551A1 (en) | Quinoline derivatives | |
AU2003280578A1 (en) | Heterocyclic compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |